A61P 15 - Drugs for genital or sexual disorders; Contraceptives

Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
12/2004
12/02/2004	US20040242459 Method for treating inflammatory diseases by administering a ppar-delta agonist
12/02/2004	US20040241803 25 human secreted proteins
12/02/2004	US20040241249 Prepared by ketone extraction of krill; evaporating ketone in liquid product; 2nd extraction of the solids in the product with an alcohol or acetate solvent to form a soluble lipid fraction; separating liquids and solids in 2nd product and evaporating solvent from liquid fraction; recovering solids
12/02/2004	US20040241245 Compositions and methods for treatment of premature ejaculation
12/02/2004	US20040241244 Neuronal growth enhancement by prostaglandin compositions and methods
12/02/2004	US20040241229 Sustained-release composition and process for producing the same
12/02/2004	US20040241224 Administering cis-clomiphene and trans-clomiphene or analogs or pharmaceutically acceptable salts or solvates thereof wherein the ratio of trans-clomiphene and cis-clomiphene is greater than 1; treatment of hypogonadism
12/02/2004	US20040241219 System comprising back layer, protective layer and at least one active-compound-containing polymer matrix comprising a polyacrylate which contains extremely reduced number of functional groups; in one embodiment polyacrylate is free of hydroxyl and/or carboxyl groups
12/02/2004	CA2526374A1 2-aminoquinoline derivatives
12/01/2004	EP1481976A1 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
12/01/2004	EP1481687A1 Use of multimeric ligands of the TNF family with reduced toxicity for treating cell proliferative diseases
12/01/2004	EP1481686A1 Use of multimeric ligands of the TNF family with reduced toxicity for treating cell proliferative diseases
12/01/2004	EP1481676A1 Phytoestrogens and probiotic for women's health
12/01/2004	EP1481667A1 NEP inhibitors for the treatment of female sexual dysfunction
12/01/2004	EP1481666A1 A composition for re-establishment of the vaginal ecosystem
12/01/2004	EP1481077A2 Mitotic kinesin inhibitors
12/01/2004	EP1480993A2 Desaturase genes, enzymes encoded thereby, and uses thereof
12/01/2004	EP1480974A1 Heterocyclylmethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors
12/01/2004	EP1480972A2 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
12/01/2004	EP1480954A1 Vanilloid receptor modulators
12/01/2004	EP1480951A1 Synthesis of indole thiazole compounds as ligands for the ah receptor
12/01/2004	EP1480624A2 Pharmaceutical tablet
12/01/2004	EP1480598A2 Manipulation of cytokine levels using cd83 gene products
12/01/2004	EP1480517A2 Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
12/01/2004	EP1368352B1 Cyclic guanosine 3',5'-monophosphate phosphodiesterase inhibitors
12/01/2004	EP1358180B1 Naphthostyril derivatives and their use as inhibitors of cyclin-dependent kinases
12/01/2004	CN1551884A Thieno 2,3-d]pyrimidines with combined LH and FSH agonistic activity
12/01/2004	CN1551883A Glycine-substituted thieno 2,3-d]pyrimidines with combined LH and FSH agonistic activity
12/01/2004	CN1551879A Stable polymorph of FLIBANSERIN, technical process for its preparation and the use thereof for preparing medicaments
12/01/2004	CN1551878A 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
12/01/2004	CN1551872A Biologically active methylene blue derivatives
12/01/2004	CN1551869A Novel compound
12/01/2004	CN1551789A Single dose aromatase inhibitor for treating infertility
12/01/2004	CN1551784A Prostaglandin compositions and methods of treatment for male erectile dysfunction
12/01/2004	CN1551774A Emergency contraceptive medicinal dose formula and medicinal composition
12/01/2004	CN1551765A Methods and materials for the treatment of testosterone deficiency in men
12/01/2004	CN1551764A Medicinal composition containing gamma-tributyrobetaine
12/01/2004	CN1551760A Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
12/01/2004	CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
12/01/2004	CN1177848C Bicyclic heteroaromatic compounds useful as LH agonists
12/01/2004	CN1177843C Novel chalcones
12/01/2004	CN1177831C New benzimidazolone-benzoxazolone-, or benzothiazoloe derivatives as ion channel modulating agents
12/01/2004	CN1177825C Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments
12/01/2004	CN1177608C Preparation of erosion of cervix
12/01/2004	CN1177583C Formulations for parenteral use of estramustine phosphate with improved pharmacological properties
11/2004
11/30/2004	US6825329 Human PEM as a target for birth control and treatment of Alzheimer's disease
11/30/2004	US6825234 Compositions and methods for amelioration of human female sexual dysfunction
11/30/2004	US6825221 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
11/30/2004	US6825207 Anticancer agents
11/30/2004	US6825200 Substituted dipeptides having nos inhibiting activity
11/30/2004	US6825198 5-HT receptor ligands and uses thereof
11/30/2004	US6825197 Cyclic GMP-specific phosphodiesterase inhibitors
11/30/2004	US6825193 Heterocyclic amines such as 4-(3,4-dichlorophenyl)-2-(2-(4-methylpiperazin-1-yl)-benzylidene) -thiomorpholin-3-one, used as antiserotonine agents
11/30/2004	US6825185 Improving the cardiovascular profile of a cox-2 selective inhibitor by administering with 3-hydroxy-3- methylglutaryl coenzyme a, an antiplatelet agent, a thrombin inhibitor or a thromboxane inhibitor
11/30/2004	US6825184 For use as anti-inflammatory agents
11/30/2004	US6824786 Topical applying cosmetic
11/30/2004	CA2298245C Matrix controlled release device
11/30/2004	CA2089309C Novel pharmaceutical uses of bilobalide and derivatives thereof and pharmaceutical compositions adapted for such use
11/25/2004	WO2004101567A1 2-SUBSTITUTED PHENYL -6,8-DIALKYL-3H-IMIDAZOLE [1,5a][1,3,5] TRIAZINE -4- ONE DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF
11/25/2004	WO2004100959A1 External patch containing estrogen and/or progestogen
11/25/2004	WO2003070197A3 RNA INTERFERENCE MEDIATED INHIBITION OF TGF-BETA AND TGF-BETA RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/25/2004	US20040236116 Novel bicyclic and tricyclic cannabinoids
11/25/2004	US20040236109 Tetrahydroquinoline derivatives
11/25/2004	US20040236104 Substituted 4-aminocyclohexanols
11/25/2004	US20040236102 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
11/25/2004	US20040236101 Heteroindanes a new class of potent cannabimimetic ligands
11/25/2004	US20040235924 antidepressants; anxiolytic agents; eating disorders; post-traumatic stress disorders; headaches;drug addition; antiinflammatory agents
11/25/2004	US20040235894 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of asthma and/or rhinitis; respiratory system disorders
11/25/2004	US20040235863 As stimulators for soluble guanylate cyclase and to their use as agents in the therapy of cardiovascular diseases, hypertonicity, thrombo-embolic diseases and ischemia, sexual dysfunction or inflammations and for the treatment of diseases of the central nervous system
11/25/2004	US20040235859 Novel piperazine derivatives
11/25/2004	US20040235846 Administering substituted nicotinamides and nicotinamide analogs for therapy of disorder responsive to the induction of apoptosis in an animal; anti-cancer agents
11/25/2004	US20040235838 Use of 2-alkoxyphenol-substituted imidazotriazinones
11/25/2004	US20040235830 Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
11/25/2004	US20040235825 Administering compounds such as N-[4-[2-[2-(1-naphthyl)propanoylamino]phenyl]butanoyl]-(3,5-dimethylisoxazol-4-yl)sulfonamide for prophylaxis and therapy of pain, allodynia, hyperalgesia, pruritus, urticaria, atopic dermatitis, contact dermatitis, allergic conjunctivitis, asthma, rhinitis, sneeze
11/25/2004	US20040235808 Administering compounds such as 17 beta -[4-(dimethylamino)-benzoyloxy]-androst-4-en-3-one for modulating a function mediated by the androgen receptor in a tissue selective manner
11/25/2004	US20040235804 Multiple dose aromatase inhibitor for treating infertility
11/25/2004	US20040235753 Oxytocin agonists
11/25/2004	US20040235722 Assay that makes use of the interaction of early pregnancy factor (EPF) or an EPF-related peptide with a human dorsal root receptor (hDRR) or hDRR related receptor; also useful to determine whether the test compound is an agonist or antagonist of hDRRs
11/25/2004	US20040235711 Immunopotentiator for mammary gland of dairy cows containing lactoferrin as an active ingredient
11/25/2004	US20040235171 Using post-transcriptional silencing to treat cell proliferative disorders associated with human papiloma viral infection; RNA interference; antitumor/antiviral agents
11/25/2004	US20040234601 Absorption in upper part oof digestive system; oral administering
11/25/2004	DE10318896A1 8beta-Vinyl-11beta-(omega-substituierte)alkyl-estra-1,3,5(10)-triene 8beta-vinyl-11beta- (omega-substituted) alkyl-estra-1,3,5 (10) -trienes
11/24/2004	EP1479684A1 Thienopyrimidines, process for preparing the same and use thereof
11/24/2004	EP1478762A2 Nucleic acid-associated proteins
11/24/2004	EP1478627A1 Method
11/24/2004	EP1478624A1 Chemical compounds
11/24/2004	EP1478620A1 Phenethanolamine derivatives for treatment of respiratory diseases
11/24/2004	EP1478613A2 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benz[a]anthracenes for selective effects on estrogen receptors
11/24/2004	EP1478394A2 Polypeptide formulation
11/24/2004	EP1478381A2 Use of soluble gamma delta t cell receptors for regulating t cell function
11/24/2004	EP1478380A2 Use of tyrosine kinase inhibitors for treating cns disorders
11/24/2004	EP1478373A1 Pharmaceutical compositions comprising one or more steroids one or more tetrahydrofolate components and vitamin b12
11/24/2004	EP1478366A1 Pharmaceutical combinations of cox-2 inhibitors and opiates
11/24/2004	EP1478361A2 Arylsulfone derivatives
11/24/2004	EP1478353A1 Sustained release pharmaceutical composition
11/24/2004	EP1313496B1 Use of a composition comprising an extract of pollen for the treatment of edema
11/24/2004	EP1313495B1 Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders
11/24/2004	EP1313493B1 Use of a composition comprising an extract of pollen for the treatment of irritability
11/24/2004	EP1313492B1 Use of a composition comprising an extract of pollen for the treatment of dysphoria
11/24/2004	EP1272201B1 Use of compatible solutes as substances having free radical scavenging properties

1 ... 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 ... 557